학술논문

1073P - Prognostic factors influencing outcome after therapy with brentuximab vedotin in patients with relapsed or refractory Hodgkin’s lymphoma
Document Type
Abstract
Source
In Annals of Oncology October 2019 30 Supplement 5:v437-v438
Subject
Language
ISSN
0923-7534